{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:56:00Z","timestamp":1780527360055,"version":"3.54.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Co-infection with <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (MTB) in human immunodeficiency virus (HIV)-infected individuals is one of the leading causes of death. Also, research on HIV and MTB (HIV-MTB) co-infection was found to have a downward trend. In this work, we performed the knowledge domain analysis and visualized the current research progress and emerging trends in HIV-MTB co-infection between 2017 and 2022 by using VOSviewer and CiteSpace. The relevant literatures in this article were collected in the Web of Science (WoS) database. VOSviewer and CiteSpace bibliometric software were applied to perform the analysis and visualization of scientific productivity and frontier. Among all the countries, USA was dominant in the field, followed by South Africa, and England. Among all the institutions, the University of Cape Town (South Africa) had more extensive collaborations with other research institutions. The <jats:italic>Int J Tuberc Lung Dis<\/jats:italic> was regarded as the foremost productive journal. Survival and mortality analysis, pathogenesis, epidemiological studies, diagnostic methods, prognosis improvement of quality of life, clinical studies and multiple infections (especially co-infection with COVID-19) resulted in the knowledge bases for HIV-MTB co-infection. The clinical research on HIV-MTB co-infection has gradually shifted from randomized controlled trials to open-label trials, while the cognition of HIV-TB has gradually shifted from cytokines to genetic polymorphisms. This scientometric study used quantitative and qualitative methods to conduct a comprehensive review of research on HIV-MTB co-infection published over the past 5 years, providing some useful references to further the study of HIV-MTB co-infection.<\/jats:p>","DOI":"10.3389\/fpubh.2023.1044426","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:34:50Z","timestamp":1675233290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Knowledge domain and emerging trends in HIV-MTB co-infection from 2017 to 2022: A scientometric analysis based on VOSviewer and CiteSpace"],"prefix":"10.3389","volume":"11","author":[{"given":"Miaona","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2174\/1568026619666190619115243","article-title":"Protease inhibitors for the treatment of HIV\/AIDS: Recent advances and future challenges","volume":"19","author":"Voshavar","year":"2019","journal-title":"Curr Top Med Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/COH.0000000000000501","article-title":"Recent progress in understanding immune activation in the pathogenesis in HIV-tuberculosis co-infection","volume":"13","author":"Du Bruyn","year":"2018","journal-title":"Curr Opin HIV AIDS."},{"key":"B3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","article-title":"Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection","volume":"16","author":"Bell","year":"2018","journal-title":"Nat Rev Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3163\/1536-5050.103.4.013","article-title":"Bibliometrics basics","volume":"103","author":"Cooper","year":"2015","journal-title":"J Med Libr Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/514561a","article-title":"Bibliometrics: Is your most cited work your best?","volume":"514","author":"Ioannidis","year":"2014","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: Vosviewer, a computer program for bibliometric mapping","volume":"84","author":"Vaneck","year":"2010","journal-title":"Scientometrics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J Inform Technol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.2196\/mhealth.8873","article-title":"The impact of mHealth interventions: Systematic review of systematic reviews","volume":"6","author":"Marcolino","year":"2018","journal-title":"JMIR MHealth UHealth."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01(E) vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1604544","article-title":"Transmission of extensively drug-resistant tuberculosis in South Africa","volume":"376","author":"Shah","year":"2017","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1811867","article-title":"A trial of a shorter regimen for rifampin-resistant tuberculosis","volume":"380","author":"Nunn","year":"2019","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01(E) vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S702","DOI":"10.1093\/infdis\/jix335","article-title":"The South African tuberculosis care cascade: Estimated losses and methodological challenges","volume":"216","author":"Naidoo","year":"2017","journal-title":"J Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2807\/1560-7917.ES.2018.23.16.17-00454","article-title":"Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): Results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013","volume":"23","author":"Cassini","year":"2018","journal-title":"Eurosurveillancel."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.3390\/ma12162540","article-title":"Antimicrobial silver nanoparticles for wound healing application: Progress and future trends","volume":"12","author":"Paladini","year":"2019","journal-title":"Materials."},{"key":"B20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1021\/acsnano.6b07343","article-title":"Immunological principles guiding the rational design of particles for vaccine delivery","volume":"11","author":"Gause","year":"2017","journal-title":"ACS Nano."},{"key":"B21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1056\/NEJMoa1809866","article-title":"HIV testing and treatment with the use of a community health approach in rural Africa","volume":"381","author":"Havlir","year":"2019","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1615822","article-title":"Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa","volume":"377","author":"Hakim","year":"2017","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cmi.2016.25","article-title":"Clash of the Cytokine Titans: Counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses","volume":"14","author":"Mayer-Barber","year":"2017","journal-title":"Cell Mol Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5588\/ijtld.17.0498","article-title":"Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries","volume":"22","author":"Tr\u00e9bucq","year":"2018","journal-title":"Int J Tuberculosis Lung Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified vaccinia virus Ankara: History, value in basic research, and current perspectives for vaccine development","volume":"97","author":"Volz","year":"2017","journal-title":"Adv Virus Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0038-1651492","article-title":"Global epidemiology of tuberculosis","volume":"39","author":"Glaziou","year":"2018","journal-title":"Semin Respir Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/bjsports-2020-103146","article-title":"Counting publications and citations is not just irrelevant: It is an incentive that subverts the impact of clinical research","volume":"55","author":"B\u00fcttner","year":"2021","journal-title":"Br J Sports Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1183\/23120541.00115-2018","article-title":"Biomarkers for tuberculosis: The case for lipoarabinomannan","volume":"5","author":"Correia-Neves","year":"2019","journal-title":"ERJ Open Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/QCO.0000000000000648","article-title":"Tuberculous meningitis: Where to from here?","volume":"33","author":"Donovan","year":"2020","journal-title":"Curr Opin Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e3428","DOI":"10.1093\/cid\/ciaa1910","article-title":"Fujifilm SILVAMP TB LAM assay on cerebrospinal fluid for the detection of tuberculous meningitis in adults with human immunodeficiency virus","volume":"73","author":"Quinn","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-4939-7717-8_20","article-title":"Progress on diagnosis of tuberculous meningitis","volume":"1754","author":"Wang","year":"2018","journal-title":"Methods Mol Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/infdis\/jiaa484","article-title":"An inflammatory composite score predicts mycobacterial immune reconstitution inflammatory syndrome in people with advanced HIV: A prospective international cohort study","volume":"223","author":"Vinhaes","year":"2021","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/life10110262","article-title":"Tuberculosis IRIS: Pathogenesis, presentation, and management across the spectrum of disease","volume":"10","author":"Quinn","year":"2020","journal-title":"Life."},{"key":"B34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/COH.0000000000000495","article-title":"Challenges of TB and HIV co-treatment: Updates and insights","volume":"13","author":"Tornheim","year":"2018","journal-title":"Curr Opin HIV AIDS."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1044426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:34:53Z","timestamp":1675233293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1044426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":34,"alternative-id":["10.3389\/fpubh.2023.1044426"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1044426","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"1044426"}}